SLE (SYSTEMIC LUPUS)
Clinical trials for SLE (SYSTEMIC LUPUS) explained in plain language.
Never miss a new study
Get alerted when new SLE (SYSTEMIC LUPUS) trials appear
Sign up with your email to follow new studies for SLE (SYSTEMIC LUPUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lupus drug begins human testing
Disease control Recruiting nowThis early-stage study is testing the safety of an experimental drug called CLN-978 in people with moderate to severe lupus. The drug is given as an injection under the skin. Researchers will enroll 24 participants whose lupus remains active despite trying at least two standard t…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 19:56 UTC
-
New drug trial targets painful lupus skin rash
Disease control Recruiting nowThis study is testing whether an experimental drug called VENT-03 can reduce the severity of skin rashes caused by lupus. About 24 adults with active lupus skin rashes will take either VENT-03 or a placebo for 4 weeks, then all will take VENT-03 for 8 more weeks. Researchers will…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated Apr 01, 2026 19:56 UTC
-
First human tests begin for potential autoimmune disease treatment
Disease control Recruiting nowThis early-stage study aims to test the safety of a new drug called NTR-1011 in healthy adults and people with lupus or rheumatoid arthritis. Researchers will give different doses to 48 participants to see how the body handles the drug and check for side effects. The main goal is…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: Neutrolis • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First human tests begin for promising new autoimmune disease drug
Disease control Recruiting nowThis early-stage study is testing a new drug called SAR448501 in adults with moderate-to-severe lupus or rheumatoid arthritis who haven't gotten enough relief from their current treatments. The main goal is to find safe dose levels and see how the drug behaves in the body. About …
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Cancer-Fighting cell therapy tested against lupus and other autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing whether a type of cell therapy called CAR-T, which is used to treat some cancers, can help people with serious autoimmune diseases like lupus, scleroderma, and vasculitis. The therapy involves collecting a patient's own immune cells, modifying th…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
CRISPR breakthrough trial targets incurable autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new treatment called CTX112 for adults with severe autoimmune diseases like lupus, scleroderma, and inflammatory muscle disease that haven't responded to standard therapies. The treatment uses genetically modified immune cells from healthy dono…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: CRISPR Therapeutics • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC